Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6177771Aexternal-prioritypatent/JPS5442995B2/ja
Priority claimed from JP6268771Aexternal-prioritypatent/JPS5442996B2/ja
Application filed by Fujisawa Pharmaceutical CofiledCriticalFujisawa Pharmaceutical Co
Publication of SE7510793LpublicationCriticalpatent/SE7510793L/
Publication of SE434841BpublicationCriticalpatent/SE434841B/xx
C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
C07D501/14—Compounds having a nitrogen atom directly attached in position 7
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
SE7510793A1971-08-141975-09-25Halogenerade cefamderivat till anvendning som mellanprodukt samt forfarande for framstellning derav
SE434841B
(sv)
3-cyancyklopentenonderivat till anvendning som utgangsmaterial for framstellning av 3-hydroxialkenylcyklopentan-1,4-diolderivat samt forfarande for framstellning av 3-cyancyklopentenonderivatet